Well, there is huge selling. Perhaps funds are repositioning and also there is probably a goodly amount of tax-loss selling since this is one of the few big losers this year. I wouldn't wait much longer as $9 includes the $.165 dividend you will get, so really paying $8.83 which is right at your 7.5%
Yes, all those who bought at $10 for the 6% dividend now have lost almost a full year's dividend. I would wait till after the last tax-loss selling day to bite into this as it will get crushed between December 15 - December 26. Too many gains in the market and very few losers to use for tax losses and this, sadly, is one of the biggies.
What a joke. He earned $1.6mm last year, has almost 5,000,000 shares and makes a truly token puchase of 10,000 to rally the troops. Suckers all!! This one is headed down the tubes on a rocket sled. See you at $4 shortly.
Balance sheet is worth $3.36/share (not that us shareholders will ever get to share in it). Biometric business is fading fast. Last year Q3 they did $4.3mm in revenue, this year $4.14mm. Last year it created a contribution to overhead of $2.1mm; this year $1.5mm. So, is the biometric business worth 2X revenue? Annualized revenue seems to be about $16-$18mm. At 2 X that is $32-$36mm or about $1.50/share. $4.86?? But then you need to discount for a company that doesn't seem to care that it is a "public" company. Definitely no value here, for sure.
See you on this board in a week. If it is $8.00 or higher I will say you had the better crystal ball. If it is below $8, then you can say that I had the better crystal ball ; )
Everytime this turd jumps 50 cents, new bagholders think they have found the Holy Grail. A week later they are stuck down 50-75 cents and become the next batch of BlackAndBlueBerries.
Only reason for posting with such negativity and zeal; Barry, they won't give you your job back cleaning toilets!!